AMLX
Price
$13.42
Change
+$0.13 (+0.98%)
Updated
Oct 3 closing price
Capitalization
1.43B
31 days until earnings call
ELDN
Price
$2.84
Change
+$0.08 (+2.90%)
Updated
Oct 3 closing price
Capitalization
170.06M
31 days until earnings call
Interact to see
Advertisement

AMLX vs ELDN

Header iconAMLX vs ELDN Comparison
Open Charts AMLX vs ELDNBanner chart's image
Amylyx Pharmaceuticals
Price$13.42
Change+$0.13 (+0.98%)
Volume$1.2M
Capitalization1.43B
Eledon Pharmaceuticals
Price$2.84
Change+$0.08 (+2.90%)
Volume$1.01M
Capitalization170.06M
AMLX vs ELDN Comparison Chart in %
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMLX vs. ELDN commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Hold and ELDN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 06, 2025
Stock price -- (AMLX: $13.42 vs. ELDN: $2.84)
Brand notoriety: AMLX and ELDN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 72% vs. ELDN: 111%
Market capitalization -- AMLX: $1.43B vs. ELDN: $170.06M
AMLX [@Biotechnology] is valued at $1.43B. ELDN’s [@Biotechnology] market capitalization is $170.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $103.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileELDN’s FA Score has 1 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • ELDN’s FA Score: 1 green, 4 red.
According to our system of comparison, ELDN is a better buy in the long-term than AMLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 2 TA indicator(s) are bullish while ELDN’s TA Score has 4 bullish TA indicator(s).

  • AMLX’s TA Score: 2 bullish, 4 bearish.
  • ELDN’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, ELDN is a better buy in the short-term than AMLX.

Price Growth

AMLX (@Biotechnology) experienced а -7.58% price change this week, while ELDN (@Biotechnology) price change was +5.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.93%. For the same industry, the average monthly price growth was +13.10%, and the average quarterly price growth was +80.18%.

Reported Earning Dates

AMLX is expected to report earnings on Nov 06, 2025.

ELDN is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+4.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX($1.43B) has a higher market cap than ELDN($170M). ELDN has higher P/E ratio than AMLX: ELDN (4.25) vs AMLX (2.69). AMLX YTD gains are higher at: 255.026 vs. ELDN (-31.068). ELDN has higher annual earnings (EBITDA): -87.9M vs. AMLX (-196.3M). AMLX has more cash in the bank: 181M vs. ELDN (108M). ELDN has less debt than AMLX: ELDN (803K) vs AMLX (5.96M). ELDN has higher revenues than AMLX: ELDN (0) vs AMLX (-249K).
AMLXELDNAMLX / ELDN
Capitalization1.43B170M842%
EBITDA-196.3M-87.9M223%
Gain YTD255.026-31.068-821%
P/E Ratio2.694.2563%
Revenue-249K0-
Total Cash181M108M168%
Total Debt5.96M803K742%
FUNDAMENTALS RATINGS
ELDN: Fundamental Ratings
ELDN
OUTLOOK RATING
1..100
41
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
16
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXELDN
RSI
ODDS (%)
Bearish Trend 4 days ago
80%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 4 days ago
85%
MACD
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 7 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
N/A
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
88%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GXYEF5.680.15
+2.67%
Galaxy Entertainment Group, Ltd.
JPSWF47.01N/A
N/A
The Japan Steel Works, Ltd.
ITEX2.52N/A
N/A
ITEX Corp.
BSLAF16.16N/A
N/A
Basler Ag
BIOF0.18N/A
-2.60%
Blue Biofuels Inc.